Lack of resveratrol neuroprotection in developing rats treated with kainic acid

Neuroscience

Volumn 230, Issue , 2013, Pages 39-49

  Friedman, L K ^a,b,c   Goldstein, B ^b   Rafiuddin, A ^b   Roblejo, P ^c   Friedman, S ^c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^c SETON HALL UNIVERSITY   (United States)

Author keywords

Development; Entorhinal cortex; Hippocampus; Oxidation; Resveratrol; Seizures

Indexed keywords

CYTOCHROME P450; GLUTAMIC ACID; KAINIC ACID; MALONALDEHYDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PROTEIN P14; PROTEIN P21; PROTEIN P60; RESVERATROL;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DRUG CLEARANCE; ELECTROENCEPHALOGRAM; ENTORHINAL CORTEX; EPILEPTIC STATE; FEMALE; HIPPOCAMPAL CA1 REGION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PEROXIDATION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME; UPREGULATION;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; BRAIN WAVES; CELL COUNT; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID AGONISTS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HIPPOCAMPUS; KAINIC ACID; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NEUROPROTECTIVE AGENTS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STATUS EPILEPTICUS; STILBENES;

EID: 84871389361     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.10.063     Document Type: Article

References (72)

1. Agrawal M., Kumar V., Kashyap M.P., Khanna V.K., Randhawa G.S., Pant A.B. Ischemic insult induced apoptotic changes in PC12 cells: protection by trans resveratrol. Eur J Pharmacol 2011, 666:5-11. PMID: 21620820.
2. Aoki C., Venkatesan Go.G.C., Mong J.A., Dawson T.M. Cellular and subcellular localization of NMDA-RI subunit lmmunoreactivity in the visual cortex of adult and neonatal rats. J Neurosci 1994, 9:5202-5222. PMID: 8083731.
3. Attwell D., Laughlin S.B. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 2001, 10:1133-1145. PMID: 11598490.
4. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Disc 2006, 5:493-506. PMID: 16732220.
5. Bradley J., Carter S.R., Rao V.R., Wang J., Finkbeiner S. Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression. J Neurosci 2006, 26:1065-1076.
6. Bruce A.J., Baudry M. Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free Radic Biol Med 1995, 18:993-1002. PMID: 7628735.
7. Cambonie G., Kamenka J., Barbanel G. Glutamate inhibition of NMDA-induced hydroxyl radical release: an ontogenic study in rat. Neuroreport 2001, 12:2035-2039. 11435942.
8. Choi J., Nordli D.R., Alden T.D., DiPatri A., Laux L., Kelley K., Rosenow J., Schuele S.U., Rajaram V., Koh S. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 2009, 6:38. PMID: 20021679.
9. Duffy T.E., Kohle S.J., Vannucci R.C. Carbohydrate and energy metabolism in perinatal rat brain: relation to survival in anoxia. J Neurochem 1975, 24:271-276. PMID: 1113105.
10. Durand G.M., Gregor P., Zheng X., Bennett M.V.L., Uhl G.R., Zukin R.S. Cloning of an apparent splice variant of the rat N-methyl-d-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc Natl Acad Sci U S A 1992, 89:9359-9363. PMID: 1409641.
11. +: implications for neurodegeneration. J Neurochem 1994, 63:584-591. PMID: 8035183.
12. Esterbauer H., Chesseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990, 186:407-421. PMID: 223308.
13. Foldes R.L., Rampersad V., Kamboj R.K. Cloning and sequence analysis of additional splice variants encoding human N-methyl-d-aspartate receptor (hNR1) subunits. Gene 1994, 147:303-304.
14. Friedman LK (2006) Calcium: a role for neuroprotection and sustained adaptation. Mol Interventions 6:315-329. Review.
15. Friedman L.K., Pellegrini-Giampietro D.E., Sperber E., Moshé S.L., Bennett M.V.L., Zukin R.S. Kainate-induced status epilepticus alters glutamate and GABAA receptor gene expression in adult rat hippocampus: an in situ hybridization study. J Neuroscience 1994, 14:2697-2707. PMID: 8182436.
16. Friedman L.K., Velísková J. GluR2 hippocampal knockdown reveals developmental regulation of epileptogenicity and neurodegeneration. Mol Brain Res 1998, 61:224-231.
17. Friedman L.K., Moshé S.L., Sperber E., Bennett M.V.L., Zukin R.S. Developmental regulation of glutamate and GABAA receptor gene expression in rat hippocampus following kainate-induced status epilepticus. Dev Neurosci 1997, 19:529-542. PMID: 9445090.
18. Friedman L.K., Avallone J., Magrys B., Liu H. Maturational effects of single and multiple early-life seizures on AMPA receptors in prepubescent hippocampus. Dev Neurosci 2007, 29:427-437. PMID: 17314473.
19. Galic M.A., Riazi K., Heida J.G., Mouihate A., Fournier N.M., Spencer S.J., Kalynchuk L.E., Teskey G.C., Pittman Q.J. Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci 2008, 28:6904-6913.
20. Galic M.A., Riazi K., Henderson A.K., Tsutsui S., Pittman Q.J. Viral-like brain inflammation during development causes increases seizure susceptibility in adult rats. Neurobiol Dis 2009, 36:343-351.
21. Gakh A.A., Anisimova N.Y., Kiselevsky M.V., Sadovnikov S.V., Stankov I.N., Yudin M.V., Rufanov K.A., Krasavin M.Y., Sosnov A.V. Dihydro-resveratrol - a potent dietary polyphenol. Bioorg Med Chem Lett 2010, 20:6149-6151. PMID: 20813524.
22. Globus M.Y., Busto R., Martinez E., Valdés I., Dietrich W.D., Ginsberg M.D. Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J Neurochem 1991, 57:470-478. PMID: 2072098.
23. Gluck M.R., Jayatilleke E., Shaw S., Rowan A.J., Haroutunian V. CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy. Epilepsy Res 2000, 39:63-71. PMID: 106960755.
24. Giulian D., Allen R.L., Baker T.J., Tomozawa Y. Brain peptides and glial growth. I. Glia-promoting factors as regulators of gliogenesis in the developing and injured central nervous system. J Cell Biol 1986, 102:803-811. PMID: 3949880.
25. González-Burgos I., López-Vázquez M.A., Beas-Zárate C. Density, but not shape, of hippocampal dendritic spines varies after a seizure-inducing acute dose of monosodium glutamate in rats. Neurosci Lett 2004, 363:22-24. PMID: 15157988.
26. Gundersen H.J., Bendtsen T.F., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., Pakkenberg B., Sorensen F.B., Vesterb A. Some new simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988, 96:379-394. Review.
27. Gupta Y.K., Briyal S., Chaudhary G. Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol Biochem Behav 2002, 71:245-249. PMID: 11812529.
28. Holmes G.L., Thompson J.L. Effects of kainic acid on seizure susceptibility in the developing brain. Dev Brain Res 1988, 39:51-59. PMID: 3359330.
29. Horak M., Wenthold R.J. Different roles of C-terminal cassettes in the trafficking of full-length NR1 subunits to the cell surface. J Biol Chem 2009, 284:9683-9691. PMID: 19188369.
30. Ishii T., Moriyoshi K., Sugihara H., Sakurada K., Kadotani H., Yokoi M., Akazawa C., Shigemoto R., Mizuno N., Masu M., et al. Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. J Biol Chem 1993, 268:2836-2843. PMID: 8428958.
31. Johnston M.V. Excitotoxicity in perinatal brain injury. Brain Pathol 2005, 15:234-240. PMID: 16196390.
32. Ren J., Fan C., Na C., Huang J., Yang Q. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem Res 2011, 36:2352-2362. PMID: 21850487.
33. Kapetanovic I.M., Muzzio M., Huang Z., Thompson T.N., McCormick D.L. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Phamracol 2011, 68:593-601.
34. Kaur J., Magrys B., Liu H., Friedman L.K. NR1 knockdown reduces seizure activity during a period of high seizure susceptibility. Neuromolecular Med 2007, 9:298-314.
35. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007, 26:3169-3179. PMID: 17581637.
36. Koudelova J., Mourek J. The lipid peroxidation in various parts of the rat brain: effect of age, hyopoxia and hyperoxia. Physiol Res 1994, 43:169-173. PMID: 7993884.
37. Li R.C., Guo S.Z., Lee S.K., Gozal D. Neuroglobin protects neurons against oxidative stress in global ischemia. J Cereb Blood Flow Metab 2010, 30:1874-1882. PMID: 20571522.
38. Liu H., Friedman L.K., Kaur J. Perinatal seizures preferentially protect CA1 neurons from seizure-induced damage in prepubescent rats. Seizure 2006, 15:1-16. PMID 16309925.
39. Milatovic D., Gupta R.C., Dettbarn W.D. Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Res 2002, 957:330-337. PMID: 12451448.
40. Morrison R.S., Wenzel H.J., Kinoshita Y., Robbins C.A., Donehower L.A., Schwartzkroin P.A. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 1996, 16:1337-1345. PMID: 8778285.
41. Moyner H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540. PMID: 7512349.
42. 2+ mobilization in the CA1 area of hippocampal slices from immature and mature rats during ischemia or glucose deprivation. Brain Res 1997, 769:158-162. PMID: 9374284.
43. Nakanishi N., Axel R., Shneider N.A. Alternative splicing generates functionally distinct N-methyl-d-aspartate receptors. Proc Natl Acad Sci U S A 1992, 89:8552-8556. PMID: 1388270.
44. Nickel B., Szelenyi I. Comparison of changes in the EEG of freely moving rats induced by enciprazine, buspirone and diazepam. Neuropharmacology 1989, 28:799-803. PMID: 2571102.
45. Nitecka L., Tremblay E., Charton G., Bouillot J.P., Berger M.L., Ben-Ari Y. Maturation of kainic acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae. Neuroscience 1984, 13:1073-1094. PMID: 6527790.
46. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358. PMID: 38810.
47. Patel M., Li Q.Y. Age dependence of seizure-induced oxidative stress. Neuroscience 2003, 118:431-437. PMID: 126997799.
48. Patel M.N. Oxidative stress, mitochondrial dysfunction, and epilepsy. Free Radic Res 2002, 36:1139-1146. PMID: 12592665.
49. Paxinos G., Watson C.R., Emson P.C. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods 1980, 3:129-149. PMID: 6610810.
50. Perez Velazquez J.L., Frantseva M.V., Carlen P.L. In vitro ischemia promotes glutamate-mediated free radical generation and intracellular calcium accumulation in hippocampal pyramidal neurons. J Neurosci 1997, 17:9085-9094. PMID: 9364055.
51. Pinard E., Tremblay E., Ben-Ari Y., Seylaz J. Blood flow compensates oxygen demand in the vulnerable CA3 region of the hippocampus during kainate-induced seizures. Neuroscience 1984, 13:1039-1049. PMID: 6441898.
52. Ren J., Fan C., Chen N., Huang J., Yang Q. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem Res 2011, 36:2352-2362. PMID: 21850487.
53. Represa A., Tremblay E., Ben-Ari Y. Kainate binding cites in the hippocampal mossy fibers: localization and plasticity. Neuroscience 1987, 20:739-748. PMID: 3037433.
54. Rizzi M., Perego C., Aliprandi M., Richichi C., Ravizza T., Colella D., Velískǒvá J., Moshé S.L., De Simoni M.G., Vezzani A. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 2003, 14:494-503. PMID: 14678756.
55. Rong Y., Baudry M. Seizure activity results in a rapid induction of nuclear factor-kappa B in adult but not juvenile rat limbic structures. J Neurochem 1996, 67:662-668. PMID: 8764593.
56. Saghyan A., LaTorre G.N., Keesey R., Sharma A., Mehta V., Rudenko V., Hallas B.H., Rafiuddin A., Goldstein B., Friedman L.K. Glutamatergic and morphological alterations associated with early life seizure-induced preconditioning. Eur J Neurosci 2010, 32:1897-1911. PMID: 21050279.
57. Sakata Y., Zhuang H., Kwansa H., Koehler R.C., Doré S. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 2010, 224:325-329. PMID: 20381489.
58. Sankar R., Shin D.H., Liu H., Mazarati A., Pereira de Vasconcelos A., Wasterlain C.G. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 1998, 18:8382-8393.
59. Shen W., Zhang C., Zhang G. Nuclear factor kappaB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca(2+) channel following severe global ischemia in rat hippocampus. Brain Res 2002, 933:23-30. PMID: 11929632.
60. Shetty A.K. Promise of resveratrol for easing status epilepticus and epilepsy. Pharmacol Ther 2011, 131:269-286. PMID: 21554899.
61. Simão F., Matté A., Matté C., Soares F.M., Wyse A.T., Netto C.A., Salbego C.G. Resveratrol prevents oxidative stress and inhibition of Na(+)K(+)-ATPase activity induced by transient global cerebral ischemia in rats. J Nutr Biochem 2011, 22:921-928. PMID: 21208792.
62. Somera-Molina K.C., Nair S., Van Eldik L.J., Watterson D.M., Wainwright M.S. Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model. Brain Res 2009, 1282:162-172.
63. Sutula T., Cascino G., Cavazos J., Parada I. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989, 26:321-330. PMID: 2508534.
64. Thornton P., Pinteaux E., Gibson R.M., Allan S.M., Rothwell N.J. Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. J Neurochem 2006, 98:258-266. PMID: 16805812.
65. Tiwari V., Chopra K. Resveratrol prevents alcohol-induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain. J Neurochem 2011, 117:678-690. PMID: 21375533.
66. Wang Q., Yu S., Simonyi A., Rottinghaus G., Sun G.Y., Sun A.Y. Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem Res 2004, 29:2105-2112.
67. Whitsett T., Carpenter M., Lamartiniere C.A. Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. J Carcinog 2006, 5:15.
68. Wu Z., Xu Q., Zhang L., Kong D., Ma R., Wang L. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res 2009, 34:1393-1400. PMID: 15662844.
69. Zhang F., Liu J., Shi J.S. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol 2010, 636:1-7. PMID: 20361959.
70. Zhang F., Shi J.S., Zhou H., Wilson B., Hong J.S., Gao H.M. Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions. Mol Pharmacol 2010, 78:466-477. PMID: 20554604.
71. Zhao X., Bausano B., Pike B.R., Newcomb-Fernandez J.K., Wang K.K., Shohami E., Ringer N.C., DeFord S.M., Anderson D.K., Hayes R.L. TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures. J Neurosci Res 2001, 64:121-131. PMID: 11288141.
72. Zukin R.S., Bennett M.V. Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 1995, 18:306-313. PMID: 7571011.